|
Volumn 116, Issue 4, 2002, Pages 851-854
|
Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis
|
Author keywords
Factor V Leiden; Hormone replacement therapy; Oestrogens; Prothrombin 20210A; Venous thrombosis
|
Indexed keywords
BLOOD CLOTTING FACTOR 5;
ESTROGEN;
PROTHROMBIN A;
ADULT;
ARTICLE;
CONTROLLED STUDY;
FEMALE;
GENE MUTATION;
HEREDITY;
HIGH RISK POPULATION;
HORMONE SUBSTITUTION;
HUMAN;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PROTEIN DEFECT;
RISK ASSESSMENT;
VEIN THROMBOSIS;
CASE-CONTROL STUDIES;
ESTROGEN REPLACEMENT THERAPY;
FACTOR V;
FEMALE;
HETEROZYGOTE;
HUMANS;
MIDDLE AGED;
MUTATION;
ODDS RATIO;
PROTHROMBIN;
RISK;
VENOUS THROMBOSIS;
|
EID: 0036125032
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0007-1048.2002.03356.x Document Type: Article |
Times cited : (145)
|
References (20)
|